Press Releases

Latest News

04-20-2010, SCHOTT North America

SCHOTT InJentle® - Innovative Staked Needle Syringe Set to Begin Mass Production in U.S.

Improved Drug stability for sensitive biopharmaceutical drugs
SCHOTT InJentle® - Innovative Staked Needle Syringe Set to Begin Mass Production in U.S.
April 20, 2009 (at INTERPHEX, New York City) – SCHOTT Pharmaceutical Systems, a division of SCHOTT North America, Inc., announced it will begin mass production of the highly innovative staked syringe system SCHOTT InJentle® in its Lebanon, Pennsylvania facility at the end of this year. The SCHOTT InJentle syringe was developed for the special requirements of highly sensitive drugs. Its unique design offers improved drug stability and a gentle application.

“The drug is not in contact with the needle or the adhesive during storage,” says Carmen Heiter, Product Manager, Syringes. “This prevents sensitive drugs from interacting with the adhesive or the metal of the needle.” The innovative seal design allows the drug to flow into the needle only at the very moment when the syringe is opened, i.e. when the needle shield is pulled off. The tamper-evident closure enables physicians or patients to determine if the syringe is still unused.

SCHOTT InJentle syringes exhibit a wide range of additional advantages. For example, the special geometry of the glass barrel does not require the use of any tungsten during the glass forming process. As a result, the syringe is completely tungsten-free. Because of the unique design, the needle point is fully protected and does not touch the needle shield or any other material.

“There is a growing segment of biotech drugs that are not only highly effective but also very sensitive,” explains Ralf Bouffleur, Vice President, Pharmaceutical Packaging, SCHOTT AG. “The reliable protection of these drugs during storage is now calling for innovative packaging solutions like the SCHOTT InJentle syringe.”

SCHOTT InJentle syringes allow for the use of particularly thin needles up to 32 gauge. “The thinner the needle,” according to Heiter, “the less painful the injection.” As the SCHOTT InJentle syringe is very simple to handle, no special training is required for healthcare personnel. “Although this syringe includes a number of special features, the syringe is delivered with standard nests and tubs,” says Heiter, “and can be filled on standard filling lines.”

SCHOTT Pharmaceutical Packaging is preparing for production of the SCHOTT InJentle syringe in its Lebanon, Pennsylvania facility. Samples in 1ml long format are available for functionality testing. “SCHOTT InJentle is both ‘drug friendly’ and ‘patient friendly,’” says Carmen Heiter. “On the one hand, it enables even very sensitive drugs to be stored safely, on the other hand it offers easy handling and the ability to use particularly thin needles for a gentle application.”

Further information
SCHOTT North America
Matthew Kraft
555 Taxter Road
10523 Elmsford
NY
Exhibitions & Events
13.
December
Exhibition Algae Europe, Madrid, Spain, 12-13 to 12-15-2016
03.
January
Exhibition 229th Meeting of the American Astronomical Society, Grapevine, Texas, USA, 01-03 to 01-07-2017
16.
January
Exhibition BAU 2017, Munich, Germany, 01-16 to 01-21-2017